HES1 and neuroblastoma: Furthermore, transduction with HES1 of several neuroblastoma cell-lines, including IMR32 and SH-SY5Y, led to inhibition of proliferation, and growth was also inhibited by treatment with recombinant Notch ligand Jag1 [43].